Prediction Markets Draw Legal Fire 16 States Challenge Platforms One Moves to Ban Momentus Shares Surge as Space Firm Secures Additional Funding via Private Placement Ella Langley Makes Chart History Simultaneously Claims Top Two Billboard Hot 100 Spots Surpassing Ariana Grande Bad Bunny and Mariah Carey Elon Musk Loses OpenAI Lawsuit Yet Legal Battles Likely to Continue Airbus Explores Potential Acquisition of Canadian Helicopter Plant Tied to Defense Contracts ACME Solar Shares Gain 3 on 25Year Power Purchase Agreement with SECI TONX Q1 2026 Earnings EPS Beat Drives 62 Stock Gain as Losses Narrow Sharply CSPI Q1 2026 Earnings 003 EPS Amidst Uncertainty TSS Inc TSSI Q1 2026 Earnings Stellar EPS Beat Drives Sharp Rally Genie Energy Ltd GNE Q1 2026 Earnings EPS Falls Short of Estimates Amidst Operational Headwinds KEQU Q1 2026 Earnings Profitability Maintained Despite Missing Revenue Disclosure PLCE Q1 2026 Earnings EPS Misses by Wide Margin as Headwinds Persist Champion Homes SKY Rallies 208 as Builders Sector Momentum Builds First Merchants Corporation Depository Shares FRMEP Holds Steady at 2505 Key Levels in Focus Sprinklr Inc CXM Gains 256 as Stock Tests Key Resistance Level enVVeno Medical NVNO Edges Higher Analyzing Recent Price Action and Key Levels Oatly OTLY Holds Steady Near Support as PlantBased Sector Faces Headwinds Indian Stock Market Opens Higher as Gift Nifty Signals Strong GapUp Start Signos Raises 20M in Funding Expands Dexcom Partnership to Capitalize on GLP1 Weight Loss Trend Iran Vows to Never Bow as Trump Rejects Peace Counteroffer Deepening Middle East Crisis US Jobless Claims Drop to Lowest Level Since MidMay Signaling Labor Market Resilience Pokemon Card Boom Fuels MultiMillion Dollar Sales as Nostalgia and Speculation Collide Global Computing Power Race Intensifies as Military Capabilities Increasingly Depend on Data Centres Indias FDI Inflows Surge 17 to 945 Billion in FY202526 as Patient Capital Replaces Hot Money 5E Advanced Materials Inc FEAM Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Phase Continues ADMA Biologics Reverses Lower Support Levels Tested After Recent Rally